WIPI2

Chr 7AR

WD repeat domain, phosphoinositide interacting 2

Also known as: ATG18B, Atg21, CGI-50, IDDSSA, WIPI-2

WD40 repeat proteins are key components of many essential biologic functions. They regulate the assembly of multiprotein complexes by presenting a beta-propeller platform for simultaneous and reversible protein-protein interactions. Members of the WIPI subfamily of WD40 repeat proteins, such as WIPI2, have a 7-bladed propeller structure and contain a conserved motif for interaction with phospholipids (Proikas-Cezanne et al., 2004 [PubMed 15602573]).[supplied by OMIM, Mar 2008]

OMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.621 OMIM phenotype
Clinical SummaryWIPI2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.34) despite low pLI — interpret in context.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.62LOEUF
pLI 0.006
Z-score 2.94
OE 0.34 (0.200.62)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.66Z-score
OE missense 0.72 (0.640.81)
204 obs / 282.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.34 (0.200.62)
00.351.4
Missense OE?0.72 (0.640.81)
00.61.4
Synonymous OE?1.11
01.21.6
LoF obs/exp: 8 / 23.3Missense obs/exp: 204 / 282.6Syn Z: -0.99

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

WIPI2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →